Skip to main content


Showing posts from August 26, 2017

Scott Edil acquires Baddi Unit of Alembic Pharma

Scott Edil acquires Baddi Unit of Alembic Pharma -The group's first inorganic move towards exports expansion -Acquired facility will be used for the growing export business  -New facility to bolster company's foray into better value formulations  Chandigarh, India, August 26, 2017: Scott Edil, a professionally managed pharmaceutical group based in Northern India today announced that its flagship company Scott Edil Pharmacia Limited (Scott Edil) has completed its ongoing transaction with Alembic Pharmaceutical Limited(Alembic) to acquire Alembic's liquid and oral solid dosage facility at Baddi.  Spread across 20,000sqm with a built-up area of 160,000sqf, the acquired facility has three manufacturing sections - Liquid syrups, tablets and capsules. This facility is equipped with state of the art machinery and well-built scalable infrastructure complying with the global standards of quality, health, environment and safety. The facility was earlier accredited with WHO GMP, PIC/s